Inhibrx Biosciences (INBX)

Inhibrx Biosciences (INBX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• INBX last traded at $82.41, 2.65% on the day.
• Inhibrx Biosciences: market cap $1.21B, P/E -9.5, revenue $3.13M over the last four quarters.
• Over the past year INBX returned 0.17%; year to date 4.32%.

Updated 2026-11-07 11:50 UTC